Cardio Diagnostics Holdings vs Heartsciences
Cardio Diagnostics Holdings is the larger business, with $14,825 of revenue in fiscal 2025 against $4,319 for Heartsciences (3.4 times as much). Heartsciences grew faster (-0.7% against -57.5%). Cardio Diagnostics Holdings kept more of each dollar of sales as profit: a net margin of -43832.5% against -211666.5%. Cardio Diagnostics Holdings carries less debt relative to equity (0.0% against 1602.3%).
| Latest fiscal year | Cardio Diagnostics HoldingsCDIO, 2025 | HeartsciencesHSCS, 2026 |
|---|---|---|
| Revenue | $14,825 | $4,319 |
| Revenue growth | -57.5% | -0.7% |
| Net income | −$6.5m | −$9.1m |
| Operating margin | -43737.5% | -194787.4% |
| Net margin | -43832.5% | -211666.5% |
| Return on equity | -78.6% | — |
| Free cash flow | −$5.9m | −$7.4m |
| Cash | $0 | $1.7m |
| Total debt | $0 | $3.6m |
| Debt to equity | 0.0% | 1602.3% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 15 | 14 |
| Market value | $4.8m | $11.6m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |